LPCN
Lipocine Inc.
Lipocine Inc. insider trading
Insiders at Lipocine Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Higuchi John W. (Director) buying $27.1K of LPCN, filed Sep 30, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $27.1K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 28, 2026
From SEC filings · last 30 days
Recent LPCN insider transactions
Higuchi John W.Director
Bought 12,561 sh at $2.16 · Sep 28, 2026
$27.1K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
LPCN insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 2 insiders traded LPCN on the open market: 4 purchases worth $434.6K and 0 sales. In the last four quarters alone: 4 purchases ($434.6K) and 0 sales, by 2 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$434.6K4 buys | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$252.2K of LPCN by Higuchi John W. (Director) on Apr 06, 2026.
Open-market transactions through Jun 30, 2026most recent first
Higuchi John W.
Director
+$81.2K
Apr 07, 2026
40,000 sh · $2.03
Higuchi John W.
Director
+$252.2K
Apr 06, 2026
123,000 sh · $2.05
Patel Mahesh V.
Chief Executive Officer · Director
+$50.8K
Apr 06, 2026
25,000 sh · $2.03
Patel Mahesh V.
Chief Executive Officer · Director
+$50.5K
Apr 02, 2026
25,000 sh · $2.02
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Apr 07, 2026 | Higuchi John W.Director | 40,000 | $2.03 | +$81.2K |
| Apr 06, 2026 | Higuchi John W.Director | 123,000 | $2.05 | +$252.2K |
| Apr 06, 2026 | Patel Mahesh V.Chief Executive Officer · Director | 25,000 | $2.03 | +$50.8K |
| Apr 02, 2026 | Patel Mahesh V.Chief Executive Officer · Director | 25,000 | $2.02 | +$50.5K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check LPCN — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Lipocine Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are LPCN insiders buying or selling?
- Between Sep 28, 2026 and Sep 28, 2026, 1 Lipocine Inc. insider made 1 open-market purchase worth $27.1K and no sales, a net purchase of $27.1K.
- How much LPCN stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 2 Lipocine Inc. insiders made 4 open-market purchases worth $434.6K and no sales. In the four quarters to Jun 30, 2026: 4 purchases ($434.6K) and no sales. The largest purchase was Higuchi John W. buying $252.2K on Apr 06, 2026.
- What was the largest recent LPCN insider trade?
- Higuchi John W. (Director) bought $27.1K of LPCN stock on Sep 28, 2026 at about $2.16 a share.
- When did an insider last buy LPCN shares?
- The most recent open-market purchase on file is Higuchi John W. (Director) buying $27.1K on Sep 28, 2026.
- Where does LPCN insider trading data come from?
- From the Form 4 filings Lipocine Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.